Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CORT

Corcept Therapeutics (CORT)

Corcept Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CORT
FechaHoraFuenteTítuloSímboloCompañía
15/05/202419:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
13/05/202411:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
01/05/202415:05GlobeNewswire Inc.Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
29/04/202407:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 4 CATALYST TrialNASDAQ:CORTCorcept Therapeutics Inc
24/04/202415:05GlobeNewswire Inc.Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
22/04/202407:00GlobeNewswire Inc.Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
15/04/202407:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)NASDAQ:CORTCorcept Therapeutics Inc
08/04/202407:00GlobeNewswire Inc.Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian CancerNASDAQ:CORTCorcept Therapeutics Inc
01/04/202407:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
15/02/202415:17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CORTCorcept Therapeutics Inc
15/02/202415:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CORTCorcept Therapeutics Inc
15/02/202415:07GlobeNewswire Inc.Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
15/02/202415:02GlobeNewswire Inc.Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical TrialNASDAQ:CORTCorcept Therapeutics Inc
14/02/202415:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CORTCorcept Therapeutics Inc
13/02/202415:46Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
08/02/202415:05GlobeNewswire Inc.Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
29/01/202407:00GlobeNewswire Inc.Corcept Appoints Roberto Vieira as President, OncologyNASDAQ:CORTCorcept Therapeutics Inc
08/01/202407:00GlobeNewswire Inc.Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase ProgramNASDAQ:CORTCorcept Therapeutics Inc
02/01/202407:00GlobeNewswire Inc.Court Finds Corcept Therapeutics’ Patents Not InfringedNASDAQ:CORTCorcept Therapeutics Inc
01/11/202315:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CORTCorcept Therapeutics Inc
01/11/202315:05GlobeNewswire Inc.Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
01/11/202307:00GlobeNewswire Inc.Corcept Appoints Monica Tellado as President, Emerging MarketsNASDAQ:CORTCorcept Therapeutics Inc
26/10/202315:05GlobeNewswire Inc.Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)NASDAQ:CORTCorcept Therapeutics Inc
25/10/202315:05GlobeNewswire Inc.Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
15/08/202316:35Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:CORTCorcept Therapeutics Inc
02/08/202315:05GlobeNewswire Inc.Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
26/07/202315:05GlobeNewswire Inc.Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
17/07/202315:05GlobeNewswire Inc.Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)NASDAQ:CORTCorcept Therapeutics Inc
27/06/202307:00GlobeNewswire Inc.Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian CancerNASDAQ:CORTCorcept Therapeutics Inc
16/06/202305:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CORTCorcept Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CORT